A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(42 sites)

United States

Loma Linda University health, Loma Linda, California

UCSF Benioff Childrens Hospital, San Francisco, California

Children's Hospital Colorado, Anchutz Medical Campus, Aurora, Colorado

Emory Children's Center, Atlanta, Georgia

Indiana University Health University Hospital, Indianapolis, Indiana